Friday 6 November 2026 Export BIO’s income statement to Excel — free account

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.

Revenue: +0.52%
EPS: +234.9%
Free cash flow: +8.07%
Total debt: +0.11%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

382.51 13.51 +3.66%

Follow BIO

Alert me

Market cap: $9.9B
P/E: 9.7×
Fwd P/E: 44.7×
Dividend yield: —
F-score: 5/9
Altman Z: 3.20
Beneish M: −2.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26 From the 10-Q filed 4 Nov	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	9.90	35.25	45.62	10.84	+8 more quarters Free account
P/S ratio Full definition →	3.90	3.03	2.90	3.20
P/FCF ratio Full definition →	30.59	22.11	20.91	21.93
P/Operating CF Full definition →	104.93	79.56	69.51	50.09
P/B ratio Full definition →	1.33	1.09	1.10	1.11
Price to Tangible BV Full definition →	1.46	1.22	1.23	1.23
EV/Sales Full definition →	3.74	2.87	2.76	3.07
EV/EBITDA Full definition →	0.00	140.08	124.19	167.85
EV/Operating CF Full definition →	20.72	15.10	14.02	14.89
EV/FCF Full definition →	29.34	20.95	19.90	21.03
Quick Ratio Full definition →	0.44	2.14	2.17	3.87
Current Ratio Full definition →	3.18	3.14	3.21	5.62
Net Debt/EBITDA Full definition →	(24.23)	(5.71)	(10.60)	2.84
Debt/Assets Full definition →	11.17%	11.74%	12.29%	11.37%
Debt/Equity Full definition →	0.16	0.17	0.18	0.16
Asset Turnover Full definition →	0.25	0.25	0.27	0.26
Operating CF/Net income Full definition →	0.21	0.27	(0.21)	0.23
Capex/Depreciation Full definition →	—	0.00	0.00	(0.28)
Interest Coverage Full definition →	(4.04)	6.00	2.77	(9.83)
Research and Development Expense of Revenue Full definition →	0.00%	9.40%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	39.17%	32.57%	35.87%	31.88%
Intangible Assets out of Total Assets Full definition →	0.06	0.07	0.08	0.07
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	8.37%
Graham Net Nets Full definition →	(0.01)	(0.01)	0.00	(0.03)
Graham Number Full definition →	493.72	224.21	186.92	414.65
Earnings Yield Full definition →	10.10%	2.84%	2.19%	9.22%
Free Cash Flow Yield Full definition →	3.27%	4.52%	4.78%	4.56%
Revenue per Share Full definition →	24.51	24.34	21.96	25.43
Operating CF per Share Full definition →	3.60	3.69	4.01	6.05
Capex per Share Full definition →	0.00	(1.20)	(1.11)	(1.68)
Free Cash Flow per Share Full definition →	3.60	2.49	2.90	4.37
Cash per Share Full definition →	0.00	60.51	58.04	56.51
Shareholders Equity per Share Full definition →	283.91	268.22	254.15	273.40
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	283.91	268.22	254.15	273.40
Free Cash Flow Full definition →	96.40	66.60	78.20	119.10
Working Capital Full definition →	2,109.50	2,059.20	2,025.10	2,389.20
Capital Expenditures Full definition →	—	(32.10)	(29.90)	(45.80)
Net Current Asset Value Full definition →	(101.50)	(57.60)	3.40	(216.70)
EV/EBIT Full definition →	0.00	140.08	124.19	167.85
Capex to Sales Full definition →	0.00	0.05	0.05	0.07
Price to Operating Income Full definition →	0.00	147.89	130.46	175.01
Other line items
Average Receivables Full definition →	443.65	455.85	425.45	456.55
Average Payables Full definition →	131.15	141.40	135.50	125.65
Average Inventory Full definition →	783.55	789.70	780.30	750.35
Average Assets Full definition →	10,239.75	10,233.05	9,658.45	9,970.30
Average Common Equity Full definition →	7,169.90	7,151.30	6,765.35	7,011.45

Show all line items

Columns are period end dates · fundamentals updated 4 Nov 2026

Stockrow Weekly